Verve Therapeutics
VERV
#6800
Rank
A$0.77 B
Marketcap
$9.18
Share price
11.24%
Change (1 day)
-55.71%
Change (1 year)

Verve Therapeutics (VERV) - Total debt

Total debt on the balance sheet as of September 2024 : A$0.11 Billion

According to Verve Therapeutics's latest financial reports the company's total debt is A$0.11 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Verve Therapeutics - Total debt on balance sheet (from 2020 to 2024)

Total debt by year

Year Total debt Change
2023-12-31A$0.10 B-8.67%
2022-12-31A$0.12 B4364.04%
2021-12-31A$2.69 M
2020-12-31N/A